Cargando…

Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial-mesenchymal transition

The aberrant expression of tumor suppressor Smad4 often occurs in colorectal cancer (CRC), and this phenomenon is believed to be associated with drug resistance. The present study aimed to investigate the effects of Smad4 on the sensitivity of CRC cells to cetuximab, and the possible mechanism under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhenlv, Zhang, Lin, Zhou, Junfeng, Zheng, Jiantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755154/ https://www.ncbi.nlm.nih.gov/pubmed/31485652 http://dx.doi.org/10.3892/mmr.2019.10597

Ejemplares similares

Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis
por: He, Chunyan, et al.
Publicado: (2023)

SMAD4 mutations do not preclude epithelial–mesenchymal transition in colorectal cancer
por: Frey, Patrick, et al.
Publicado: (2021)

Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
por: Schmitz, Sandra, et al.
Publicado: (2015)

Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition
por: Kitahara, Hiroko, et al.
Publicado: (2016)

Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling Pathways
por: Liu, Shu-Fen, et al.
Publicado: (2012)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

MicroRNA-455-3p Inhibits Tumor Cell Proliferation and Induces Apoptosis in HCT116 Human Colon Cancer Cells
por: Zheng, Jiantao, et al.
Publicado: (2016)

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling
por: Song, Yang, et al.
Publicado: (2019)

GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer
por: Qin, Xuke, et al.
Publicado: (2023)

miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition
por: Zhao, Senlin, et al.
Publicado: (2017)

Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5
por: Li, Siwei, et al.
Publicado: (2019)

CDCA7 promotes TGF‐β‐induced epithelial–mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC
por: Li, Hongyi, et al.
Publicado: (2022)

TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017)

Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma
por: Chen, Xueran, et al.
Publicado: (2017)

Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT(1) and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
por: Yu, Qun, et al.
Publicado: (2022)

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling
por: Devine, Daniel J., et al.
Publicado: (2013)

Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway
por: Guan, Sibin, et al.
Publicado: (2017)

PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition
por: Weng, Xingyue, et al.
Publicado: (2019)

Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
por: Chen, Peng, et al.
Publicado: (2020)

HER4 promotes the progression of colorectal cancer by promoting epithelial-mesenchymal transition
por: Jia, Xiaojing, et al.
Publicado: (2020)

CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition
por: Qiu, Lin, et al.
Publicado: (2017)

MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway
por: Yang, Yu, et al.
Publicado: (2019)

LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2014)

Claudin-7 promotes the epithelial – mesenchymal transition in human colorectal cancer
por: Philip, Rahel, et al.
Publicado: (2014)

HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018)

PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis
por: Méndez-Vidal, C, et al.
Publicado: (2013)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
por: Zhang, Zizhen, et al.
Publicado: (2020)

CD82 attenuates TGF-β1-mediated epithelial-mesenchymal transition by blocking smad-dependent signaling in ARPE-19 cells
por: Lee, Hyesook, et al.
Publicado: (2022)

Role of Smad3 signaling in the epithelial-mesenchymal transition of the lens epithelium following injury
por: Meng, Fanlan, et al.
Publicado: (2018)

Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells
por: Hu, Chun-Sheng, et al.
Publicado: (2021)

Gland Attenuation, a Novel Morphological Feature of Colorectal Cancer: Evidence for an Epithelial-Mesenchymal Transition
por: Baek, Tae-Hwa, et al.
Publicado: (2018)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation
por: Li, Wenlu, et al.
Publicado: (2018)

MDM2 promotes epithelial–mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
por: Chen, Wei, et al.
Publicado: (2017)

Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
por: Zhou, Xian-Long, et al.
Publicado: (2017)

GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
por: Huang, Qi, et al.
Publicado: (2020)

Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Du, Qiang, et al.
Publicado: (2023)

Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition
por: Geng, Chang-Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvutuusrja4kj6rfel3tst3t2r